Legacy Wealth Asset Management, LLC Abb Vie Inc. Transaction History

Legacy Wealth Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $1.16 Million - $1.32 Million	-10,929 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $12,204 - $13,596	116 Added 1.07%	10,929 $1.23 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $24,654 - $27,141	241 Added 2.28%	10,813 $1.17 Million
Q4 2020 Mar 25, 2021	BUY	$80.49 - $108.67 $850,940 - $1.15 Million	10,572 New	10,572 $1.13 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.